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Abstract Thyroid hormone (TH) regulates mitochondrial
respiratory rate by activating coordinated transcription in the
nucleus and mitochondria. Whereas TH activates transcription
of mitochondrial genes directly, the activation of nuclear-encoded
mitochondrial genes is probably executed by indirect unknown
mechanisms. Nuclear respiratory factors (NRF)-1 and GA-
binding protein (BP)/NRF-2 may function as transacting genes,
but regulation of these genes by TH is not demonstrated. We
show that TH administration to hypothyroid rats promptly
increases GABP/NRF-2 K-subunit mRNA levels in the liver,
without significant changes in L, Q subunits. In run-on and time-
course experiments, the transcription rate and protein levels
increased three-fold in response to TH, indicating GABP/NRF-2
transcriptional regulation. The results also support the notion
that ATP synthase L-subunit is regulated by TH through the
indirect activation of GABP/NRF-2. ß 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
GA-binding protein/nuclear respiratory factor-2 (GABP/
NRF-2) is an ubiquitously expressed nuclear transcription
factor that has been involved in a broad range of cellular
processes, such as the activation of some nuclear-encoded
mitochondrial genes [1^5], the induction of interleukin-2 dur-
ing T-cell activation [6] or, more recently, the regulation of
synapse-speci¢c gene expression at the neuromuscular junc-
tion [7]. The biogenesis of mitochondria requires the expres-
sion of genes both from the nuclear and mitochondrial ge-
nomes, the mitochondrial function depending on the precise
cross-regulation of the two genomes expression [8]. However,
the mechanisms that control this coordinated expression are
not well known. In this respect, it is interesting that the thy-
roid hormone (TH), which is long known to modulate the
mitochondrial respiratory rate in response to the varying en-
ergy demands [9], stimulates transcription both in the nucleus
and mitochondria. The direct regulation of mitochondrial
RNA synthesis by TH has been demonstrated recently in
vivo [10]. Nevertheless, the overall mechanisms that allow
TH-transcriptional activation of the nuclear-encoded respira-
tory subunits, although known of certain genes for a long
time, are still far from being completely understood. It is
generally accepted that the low sequence conservation of the
TRES present in these genes promoters [11] makes most likely
that TH exerts control by indirect mechanisms, regulating the
expression of common transcription factors required for the
expression of these genes. NRF-1 and GABP/NRF-2 have
been implicated in the expression of many respiratory sub-
units along with key components of the mitochondrial tran-
scription, replication and haem biosynthetic machinery [12].
A transacting gene (for example NRF-1 or GABP/NRF-2)
might be activated by TH and in turn transactivate the OX-
PHOS promoters. However, the transcriptional regulation of
NRF-1 and GABP/NRF-2 by TH has not been demonstrated
to date. In this paper, we have examined this issue in the liver
of hypothyroid and triiodothyronine (T3)-treated hypothyroid
rats and found that T3 speci¢cally activates the expression of
the DNA-binding K-subunit of the heteromeric GABP/NRF-2
nuclear transcription factor.
2. Materials and methods
2.1. Animals treatment and tissue sampling
Adult male Wistar rats (about 200 g) grown in our animal facilities
were used. Hypothyroidism was induced by surgical thyroidectomy
and the supply of 0.04% 2-mercapto-1-methylimidazole (an inhibitor
of TH synthesis) in the drinking water for over 1 month prior starting
the experiment. T3 (20 Wg/100 g body weight) was administered daily
by intraperitoneal injections for 3 days. In the time-course experi-
ments, animals were killed after a single injection at the times indi-
cated. The animals were killed by decapitation and their livers quickly
dissected and frozen in liquid nitrogen.
2.2. RNA extraction and Northern analysis
Total RNA was obtained by guanidine and caesium chloride puri-
¢cation [13]. For Northern blots, 20 Wg of total RNA were separated
on a 1% (w/v) agarose/formaldehyde gel and transferred onto nylon
membranes with 20USSC (1USCC = 150 mM NaCl, 15 mM sodium
citrate, pH 7.0). Probes for GABP/NRF-2 K, L, Q-subunits, mitochon-
drial transcription factor A (Tfam) and ATP synthase L-subunit have
been described previously [14]. Human S26 ribosomal protein probe
[15] was kindly provided by Dr T. Tanaka and was used to normalise
the amount of RNA loaded per lane. Probes were labelled with 32P
using a random priming system. Hybridisation and washing were
carried out as described by Church and Gilbert [16].
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2.3. Run-on analysis
To measure the transcriptional activity of the NRF-2 K-subunit
gene, we isolated nuclei from the livers of hypothyroid or T3-treated
hypothyroid rats. Brie£y, nuclei from 1 g of liver were isolated
through a 2 M-sucrose cushion as described [4]. Nuclei storage, in
vitro run-on transcription assays, and hybridisation conditions were
carried out as described [17]. The following undigested plasmids were
denatured and immobilised on nylon ¢lters: rat GABP/NRF-2 K-sub-
unit and ATP synthase L-subunit, and human L-actin. Rat ATP syn-
thase L-subunit and human L-actin cDNAs were kindly provided by
Dr J.M. Cuezva [4].
2.4. Protein extraction and Western analysis
Total liver extracts were obtained either by homogenising in me-
dium 210 mM mannitol, 70 mM sucrose, 1 mM EDTA, 5 mM HCl^
Tris, pH 7.5 [18], plus protease inhibitors (phenylmethylsulfonyl £uo-
ride, E-64, pepstatin A) or in boiling medium 65 mM Tris^HCl, pH
6.8, 10% glycerol, 0.14 M mercaptoethanol, 2% SDS, followed by
centrifuging at 17 400Ug for 20 min [19]. Proteins (50 Wg) were sep-
arated in 10% SDS^polyacrylamide gels and transferred to PVDF
membranes. The Western blots were probed with GABP/NRF-2 K-
subunit antibody at 1:2000 dilution; the antibody was produced for
us by Isogen Bioscience BV (The Netherlands) against peptide IS-
DETSEQVTRWAA. Protein disul¢de-isomerase antibody (kind gift
of Dr J.G. Castan‹o) [20] was used to control load; the expression of
this protein is not a¡ected by the di¡erent thyroid status of the ani-
mal. As secondary antibody, an anti-rabbit peroxidase conjugate (Bio-
Rad) at 1:3300 dilution was employed with both primary antibodies.
The immunoreactive proteins were visualised by chemiluminescence
(ECL detection system; Amersham)
3. Results
3.1. T3 increases expression of GABP/NRF-2 K-subunit mRNA
in hypothyroid liver
The expression of NRF-1 and GABP/NRF-2 genes was
studied in parallel with those of Tfam, the mitochondrial tran-
scription factor, and ATP synthase L-subunit, a nuclear-en-
coded mitochondrial gene known to respond to THs. Whereas
ATP synthase L-subunit, Tfam and NRF-1 are encoded each
by one gene, GABP/NRF-2 is encoded by three genes giving
K, L, and Q-subunits, in the NRF nomenclature [21] or other-
wise K, L1, and L2-subunits, in the GABP one [22]. NRF-2 is
the human homologue of the mouse GABP [21]. Only the K-
subunit, that belongs to the ETS family of regulatory proteins
[23], has DNA-binding activity. Although the K-subunit binds
DNA weakly, the heterodimerisation with the L-subunit pro-
vides the active form of GABP/NRF-2, an K2L2 heterotetra-
mer, with the ability to bind avidly to tandem GGAA (ets)
sites [21,22]. The analysis of the mRNA levels in the liver of
control, hypothyroid and T3-treated hypothyroid rats (Fig. 1)
indicated that T3 increased signi¢cantly (P6 0.001) the
mRNA levels of GABP/NRF-2 K-subunit without changing
those of L or Q-subunits. The presence of two transcripts in the
GABP/NRF-2 K-subunit mRNA was described previously
[19,22]. Smaller increases (P6 0.05) were observed in the
NRF-1 or Tfam levels upon T3 treatment. In accordance
with previous reports [24,25], T3 increased signi¢cantly
(P6 0.001) the level of ATP synthase L-subunit mRNA. In
our experiments, a three-fold increase over control livers was
observed for both GABP/NRF-2 K-subunit and ATP synthase
L-subunit. Therefore, T3 increased speci¢cally the expression
of GABP/NRF-2 K-subunit.
3.2. Time-course of GABP/NRF-2 K-subunit mRNA induction
by T3
In order to study the kinetics of GABP/NRF-2 K-subunit
mRNA activation, hypothyroid rats were treated with a single
T3 dose. Livers from individual rats were dissected at various
times after T3 injection. Total RNA was isolated and analysed
by Northern blot. Fig. 2 shows that T3 increased the accumu-
lation of GABP/NRF-2 K-subunit transcripts shortly after the
hormone administration. The autoradiographic signals were
corrected for load control with a probe from the ribosomal
protein S26, a gene expressed at a constant level in mamma-
lian tissues in di¡erent physiological contexts [15]. The quan-
titative analysis showed that GABP/NRF-2 K-subunit induc-
tion took place in two peaks, the ¢rst detected 30 min after T3
injection with a two-fold increase in the mRNA level, and a
second one after 16 h with a three-fold increase. The expres-
sion kinetics of Tfam and ATP synthase L-subunit mRNAs
were also analysed in the same samples. The Tfam mRNA
levels showed a negligible response to T3, thus con¢rming the
results obtained in the steady state (Fig. 1). In contrast, ATP
synthase L-subunit mRNA increased steadily, reaching a max-
imum at 16 h. The data therefore indicated that the GABP/
NRF-2 K-subunit induction preceded that of ATP synthase L-
subunit, thus suggesting that the control of this gene by T3
was mediated by GABP/NRF-2. This is in agreement with the
previous demonstration that the ATP synthase L-subunit pro-
moter contains response elements for GABP/NRF-2 [26].
3.3. T3 activates GABP/NRF-2 K-subunit transcription
The rapid accumulation of GABP/NRF-2 K-subunit tran-
scripts following T3 administration suggested that the regula-
tion was due to the transcriptional activation of the gene. To
determine whether T3 modulates GABP/NRF-2 K-subunit
transcription rate, we performed run-on assays with isolated
nuclei from the livers of hypothyroid or hypothyroid T3-
treated rats (Fig. 3). The transcription rate of the GABP/
NRF-2 K-subunit gene was compared with that obtained for
L-actin, a gene whose expression is not a¡ected by T3, and for
ATP synthase L-subunit, that is transcriptionally activated by
TH in liver [27]. The relative rate of GABP/NRF-2 K-subunit
gene transcription increased 3.4-fold after 30 min of T3 injec-
tion and 2.2-fold, 19 h later. Interestingly, the transcription
rate of the ATP synthase L-subunit gene was increased 2.4-
fold only after 19 h of injection, with no change observed at
the 30 min time. These data provide clear evidence for a direct
e¡ect of T3 on the transcription rate of the GABP/NRF-2 K-
subunit gene in vivo, and support the notion that the tran-
scriptional regulation of the ATP synthase L-subunit gene by
T3 is mediated by GABP/NRF-2 activity.
3.4. GABP/NRF-2 K-subunit protein level increases in response
to T3
The time-course expression of GABP/NRF-2 K-subunit
protein was also analysed by Western blotting in the livers
of hypothyroid rats after T3 injection. The immunoreactive
signals were corrected for load control by the signal given
at each time by protein disul¢de-isomerase antibody, which
recognises a protein whose expression in the liver is not af-
fected by the thyroid status of the rat. As shown in Fig. 4, the
quantitative analysis indicated that the level of GABP/NRF-2
K-subunit protein increased steadily from the administration
time up to 60 min, when nearly a three-fold increase was
observed. Afterwards, it returned to the control level after
about 24 h of hormone administration. The kinetics of protein
accumulation (Fig. 4) di¡ered somewhat from that of mRNA
FEBS 25862 28-3-02
A. Rodr|¤guez-Pen‹a et al./FEBS Letters 514 (2002) 309^314310
Fig. 1. T3-treatment increases GABP/NRF-2 K-subunit mRNA levels in hypothyroid liver. Total RNA was extracted from the liver of un-
treated control (C), hypothyroid (H) and hypothyroid rats previously injected with a dose of T3 for 3 days (T3), which leads to a severe hyper-
thyroid state. Northern analysis was performed as described in Section 2. Representative autoradiograms after hybridisation with probes for
the di¡erent GABP/NRF-2 K, L and Q-subunits are shown. The same Northerns were hybridised with probes for Tfam, NRF-1 and ATP syn-
thase L-subunit. The autoradiographic signals from four di¡erent animals per experimental group and two di¡erent experiments were corrected
for loading with the L-actin probe and expressed as fold-stimulation (means þ S.D.) over control levels. The signi¢cant increases are marked,
*P6 0.05; ***P6 0.001.
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(Fig. 2), probably indicating that post-transcriptional mecha-
nisms are also involved in the maintenance of the protein
level, as suggested previously [19]. Therefore, GABP/NRF-2
K-subunit protein concentration also increased in response to
T3.
4. Discussion
We have investigated the expression of NRF-1 and GABP/
NRF-2 in the liver of control, hypothyroid and T3-treated
hypothyroid rats. Two other genes were also studied in paral-
lel, the mitochondrial transcription factor Tfam, which has
promoter recognition sites for both NRF-1 and GABP/
NRF-2, and ATP synthase L-subunit, whose transcription is
regulated by TH and has sites for GABP/NRF-2. We found
that the mRNA steady-state level of GABP/NRF-2 K-subunit
increased three-fold in the liver of T3-treated hypothyroid rats
after hormone injection (Fig. 1). In contrast, the transcripts of
L and Q-subunits were not a¡ected. NRF-1 and Tfam showed
little accumulation of their mRNAs. In accordance with pre-
vious results [24,25], the ATP synthase L-subunit mRNA was
found increased in the liver of T3-treated hypothyroid rats.
The time-course experiments (Fig. 2) indicated that the accu-
mulation of GABP/NRF-2 K-subunit transcripts in response
to T3 was very rapid, and the run-on experiments (Fig. 3)
indicated that this accumulation was due to increased tran-
scription rates induced by the hormone. The time-course ex-
periments (Fig. 4) also showed a rise in the protein level of
GABP/NRF-2 K-subunit 1 h after T3 injection, that returned
to control levels after 24 h. Thus, our results indicate that TH
speci¢cally increases GABP/NRF-2 K-subunit expression and
this is probably enough to activate GABP/NRF-2 (see below).
We found previously in rat tissues [14] that the mRNA
steady-state level of K-subunit is much lower than those of
the L and Q-subunits, what may make K-subunit limiting for
complex assembly and a subject of regulation. The results
presented here also indicate that of the two nuclear respira-
tory factors, TH speci¢cally activates GABP/NRF-2 when
compared with NRF-1. Whether TH activates via direct or
indirect mechanisms remains to be established. The Tfam data
were quite unexpected in light of the presence of GABP/NRF-
2 recognition sites (in addition to NRF-1) in its promoter. In
adaptive thermogenesis, the induction of PGC-1, a transcrip-
tional co-activator of nuclear receptors, leads to mitochon-
drial proliferation, with induction of NRF-1 and GABP/
NRF-2, which in turn activate Tfam promoter activity [28].
These authors observed that Tfam activation is abolished by
mutation of NRF-1-binding site but only slightly a¡ected by
that of GABP/NRF-2. Their results and ours may suggest
that, in the absence of a certain level of NRF-1, GABP/
NRF-2 plays only a marginal role in Tfam in vivo expression.
Fig. 2. Time-course of mRNAs induction in the liver after T3-treatment of hypothyroid rats. Hypothyroid rats were injected with a single dose
of T3 and killed at the indicated times. RNA was extracted and analysed by Northern blot by hybridising with GABP/NRF-2 K-subunit,
Tfam, ATP synthase L-subunit probes and the ribosomal protein S26 probe. On the right, the quantitative analysis is shown after correction
for loading with the S26 signal and normalisation for the signal at time 0. The data are from one out of two independent experiments carried
out with similar results.
Fig. 3. T3-stimulation of GABP/NRF-2 K-subunit and ATP syn-
thase L-subunit genes transcription rates in isolated nuclei of hypo-
thyroid rats. Nuclei from livers of hypothyroid (H), or hypothyroid
rats killed after 30 min (T3, 30P) or 19 h (T3, 19 h) of a single injec-
tion of T3 were used to generate 32P-labelled run-on transcription
probes, as described in Section 2. The labelled RNA probes were
hybridised to nylon membranes containing 10 Wg of plasmid DNA
for L-actin, GABP/NRF-2 K-subunit, and ATP synthase L-subunit.
The signals obtained are shown together with the fold stimulation
of the transcription rates calculated from the densitometric analysis.
The data are from one out of two independent experiments carried
out with similar results
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On the contrary, the data regarding ATP synthase L-subunit
expression were straightforward. Our results from the time-
course and run-on experiments (Figs. 2 and 3) showed for the
¢rst time that the induction of GABP/NRF-2 K-subunit pre-
ceded the increase in ATP synthase L-subunit expression, thus
supporting that the TH-transcriptional activation of ATP syn-
thase L-subunit is indirect, exerted via GABP/NRF-2 activa-
tion. In support of these results, previous analysis of TH-bind-
ing sites in the human promoter [29] indicated that the
putative response elements were non-functional.
In summary, we show that TH in vivo activates expression
of GABP/NRF-2, one of the two nuclear respiratory factors
suggested to coordinate expression of the nuclear and mito-
chondrial genomes. The activation is produced via the in-
crease in expression of GABP/NRF-2 K-subunit. We also
show that this accumulation precedes activation of ATP syn-
thase L-subunit, a gene known to be regulated by TH and
GABP/NRF-2. The results thus support the notion that the
TH activation of nuclear-encoded mitochondrial genes is ex-
erted through indirect means.
Acknowledgements: We thank A.M. Seguido for technical assistance
and P. Sen‹or and F. Nun‹ez for taking care of the animals. This work
was supported by Grant PM97-0066 from the Direccio¤n General de
Ensen‹anza Superior e Investigacio¤n Cient|¤¢ca (Ministerio de Ciencia y
Tecnolog|¤a, Spain). H.E. and A.C.H. were supported by a collabora-
tion contract between CSIC and Biotools S.A.
References
[1] Joste, V., Goitom, Z. and Nelson, B.D. (1989) Eur. J. Biochem.
184, 255^260.
[2] Luciakova, K. and Nelson, B.D. (1992) Eur. J. Biochem. 207,
247^251.
[3] Wiesner, R.J., Kurowski, T.T. and Zak, R. (1992) Mol. Endo-
crinol. 6, 1458^1467.
[4] Izquierdo, J.M. and Cuezva, J.M. (1993) FEBS Lett. 323, 109^
112.
[5] Zhang, C. and Wong-Riley, M.T. (2000) Eur. J. Neurosci. 12,
1013^1023.
[6] Ho¡meyer, A., Avots, A., Flory, E., Weber, C.K., Ser£ing, E.
and Rapp, U.R. (1998) J. Biol. Chem. 273, 10112^10119.
[7] Briguet, A. and Ruegg, M.A. (2000) J. Neurosci. 20, 5989^5996.
[8] Garesse, R. and Vallejo, C.G. (2001) Gene 263, 1^16.
[9] Pillar, T.M. and Seitz, H.J. (1997) Eur. J. Endocrinol. 136, 231^
239.
[10] Enriquez, J.A., Fernandez-Silva, P., Garrido-Perez, N., Lopez-
Perez, M.J., Perez-Martos, A. and Montoya, J. (1999) Mol.
Cell. Biol. 19, 657^670.
[11] Li, R., Luciakova, K., Zaid, A., Betina, S., Fridell, E. and Nel-
son, B.D. (1997) Mol. Cell. Endocrinol. 128, 69^75.
[12] Scarpulla, R.C. (1997) J. Bioenerg. Biomembr. 29, 109^119.
[13] Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular
Cloning: A Laboratory Manual, Cold Spring Harbor Laborato-
ry, Cold Spring Harbor, NY.
[14] Escriva, H., Rodriguez-Pen‹a, A. and Vallejo, C.G. (1999) Bio-
chimie 81, 965^971.
[15] Vincent, S., Marty, L. and Fort, P. (1993) Nucleic Acids Res. 21,
1498.
[16] Church, G.M. and Gilbert, W. (1984) Proc. Natl. Acad. Sci.
USA 81, 1991^1995.
[17] Rodriguez-Pen‹a, A., Ibarrola, N., In‹ iguez, M.A., Mun‹oz, A. and
Bernal, J. (1993) J. Clin. Invest. 91, 812^818.
[18] Larsson, N.G., Garman, J.D., Oldfors, A., Barsh, G.S. and Clay-
ton, D.A. (1996) Nat. Genet. 13, 296^302.
[19] Vallejo, C.G., Escriva, H. and Rodriguez-Pen‹a, A. (2000) Bio-
chimie 82, 1129^1133.
[20] Nieto, A., Mira, E. and Castan‹o, J.G. (1990) Biochem. J. 267,
317^323.
Fig. 4. Time-course of liver GABP/NRF-2 K-subunit protein expression after T3-treatment of hypothyroid rats. Total liver extracts were ob-
tained from hypothyroid rats (time 0) or hypothyroid rats killed at the indicated times after a single injection of T3. The Western blots were
probed with GABP/NRF-2 K-subunit and PDI antibodies, as indicated in Section 2. The various time signals were corrected for protein loading
with the PDI signal and the ¢nal quanti¢cation normalised for the signal at time 0.
FEBS 25862 28-3-02
A. Rodr|¤guez-Pen‹a et al./FEBS Letters 514 (2002) 309^314 313
[21] Virbasius, J.V., Virbasius, C.A. and Scarpulla, R.C. (1993) Genes
Dev. 7, 380^392.
[22] Thompson, C.C., Brown, T.A and McKnight, S.L. (1991) Science
253, 762^768.
[23] Wasylyk, B., Hahn, S.L. and Giovane, A. (1993) Eur. J. Bio-
chem. 211, 7^18.
[24] Izquierdo, J.M., Jimenez, E. and Cuezva, J.M. (1995) Eur. J.
Biochem. 232, 344^350.
[25] Guerrieri, F., Kalous, M., Adorisio, E., Turturro, N., Santoro,
G., Drahota, Z. and Cantatore, P. (1998) J. Bioenerg. Biomembr.
30, 269^276.
[26] Villena, J.A., Vin‹as, O., Mampel, T., Iglesias, R., Giralt, M. and
Villarroya, F. (1998) Biochem. J. 19, 121^127.
[27] Izquierdo, J.M. and Cuezva, J.M. (1993) FEBS Lett. 323, 109^
112.
[28] Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G.,
Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R.C. and
Spiegelman, B.M. (1999) Cell 98, 115^124.
[29] Martin, I., Villena, J.A., Giralt, M., Iglesias, R., Mampel, T.,
Vin‹as, O. and Villarroya, F. (1996) Mol. Cell. Biochem. 154,
107^111.
FEBS 25862 28-3-02
A. Rodr|¤guez-Pen‹a et al./FEBS Letters 514 (2002) 309^314314
